ArticleCancer reports (Hoboken, N.J.)2022

Unified model involving genomics, magnetic resonance imaging and prostate-specific antigen density outperforms individual co-variables at predicting biopsy upgrading in patients on active surveillance for low risk prostate cancer.

Alp Tuna Beksac et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.